about
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob miceKinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in HumansIncretin based therapies: a novel treatment approach for non-alcoholic fatty liver diseaseCalorie restriction and endurance exercise share potent anti-inflammatory function in adipose tissues in ameliorating diet-induced obesity and insulin resistance in mice.Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study.Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementTreatment of dyslipidemia in patients with type 2 diabetes.Endothelial dysfunction in insulin resistance and type 2 diabetes.Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentClinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register.Is insulin resistance the cause of the metabolic syndrome?Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels.Pathogenesis and treatment of diabetic vascular disease - illustrated by two cases.Molecular diversity and evolution of the large lipid transfer protein superfamily.A 3-year follow-up study of β-cell function in patients with early-onset type 2 diabetesEffects of isoflavones on lipid and apolipoprotein levels in patients with type 2 diabetes in Heilongjiang Province in China.Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up studyPrevalence of Type 2 Diabetes Mellitus among Urban Sikh Population of Amritsar.Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus.Kinetic studies to investigate lipoprotein metabolism.Lipidomic analysis of serum from high fat diet induced obese mice.Plasma Lipidome Analysis by Liquid Chromatography-High Resolution Mass Spectrometry and Ion Mobility of Hypertriglyceridemic Patients on Extended-Release Nicotinic Acid: a Pilot Study.Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins.Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo.LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.Endogenous versus exogenous fatty acid availability affects lysosomal acidity and MHC class II expression
P2860
Q24629441-D267BA3C-AFD0-442C-8DBA-A85E16502749Q26774776-845DF86B-60DC-4026-8CF9-13B4020606A2Q26827183-3405671D-2D9D-4958-8943-865E6A6160DCQ30435237-B9AB7B12-5608-4788-AEDE-2B344C098175Q30829796-D2DDAE2C-B09D-4EBA-8A8A-775614F4DEC7Q34181381-C1F9348D-D74E-43D4-8E65-7D364CEE5027Q34499472-9715ED5C-009F-4EC7-9F33-E44C970A3D4EQ34655075-749141E6-51DE-4A83-86A0-3AA3BADA0154Q35029623-5100CC9A-3F21-4757-9A09-8B827D0E1E16Q35179874-A2416226-C70B-4D08-9FA3-49ED4FA38E38Q36383033-39F012F5-ACA1-4273-B195-8D1649BF7D9AQ36430298-1A51D17F-11B5-4C2A-ADD3-4A9C29816628Q36623110-0DA033A7-3B32-48F0-B717-C383DBA59DB1Q36674717-9CA6AC6D-1B8B-4943-B752-F369CDB1E91EQ37107776-CB881FD1-6A90-4A00-B97A-013BF3604CCFQ37247016-A130FE41-04E2-4D72-BB0E-8D43033A52EEQ37336662-1C5BCAD4-6F9B-4018-A866-3B6542403F27Q37419776-A90A2104-1485-4E62-BC3A-A5C5E91AA992Q37773162-671B6476-F6E0-4206-B8D7-2017D1017343Q37964792-E591EE9D-0FBE-4CE6-A1D1-4B6A00BF61E4Q38345748-D6EA9121-EE5B-43DB-A2AC-26EC1730C18EQ38656143-73E97E79-6004-4E6C-8E74-38EE72874556Q41885419-97B92AA5-BC8C-42D7-85C0-B1E49588FECEQ42499996-230F8160-A674-4A78-8733-C55615F37E19Q46942263-C9D5E7D6-10EC-4F43-8DFE-4A5CE95630FDQ57375107-BD7AE11A-2922-4AA2-B0CE-457188B84FD5
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Type 2 diabetes as a lipid disorder.
@ast
Type 2 diabetes as a lipid disorder.
@en
type
label
Type 2 diabetes as a lipid disorder.
@ast
Type 2 diabetes as a lipid disorder.
@en
prefLabel
Type 2 diabetes as a lipid disorder.
@ast
Type 2 diabetes as a lipid disorder.
@en
P356
P1476
Type 2 diabetes as a lipid disorder
@en
P2093
Taskinen MR
P304
P356
10.2174/1566524053766086
P577
2005-05-01T00:00:00Z